Terms: = Kidney tumors AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Prognosis
8 results:
1. P53, CK20, and fgfr3 Overexpression is Associated with the Characteristics of Urothelial Cell Carcinoma of the Bladder.
Asgari M; Firouzi F; Abolhasani M; Bahadoram M; Barahman M; Madjd Z; Mehrazam M; Hassanzadeh S; Akade E
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3125-3131. PubMed ID: 37774064
[TBL] [Abstract] [Full Text] [Related]
2. Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma.
Deng Q; Du Y; Wang Z; Chen Y; Wang J; Liang H; Zhang D
BMC Genomics; 2023 Jun; 24(1):307. PubMed ID: 37286941
[TBL] [Abstract] [Full Text] [Related]
3. Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.
Rogala J; Kojima F; Alaghehbandan R; Ptakova N; Bravc A; Bulimbasic S; Perez Montiel D; Slisarenko M; Ali L; Kuthi L; Pivovarcikova K; Michalova K; Bartovic B; Bartos Vesela A; Dolejsova O; Michal M; Hes O
Bosn J Basic Med Sci; 2022 Jul; 22(4):531-539. PubMed ID: 35276058
[TBL] [Abstract] [Full Text] [Related]
4. Evolving Role of Genomics in Genitourinary Neoplasms.
Devitt ME; Dreicer R
Acta Med Acad; 2019 Apr; 48(1):68-77. PubMed ID: 31264434
[TBL] [Abstract] [Full Text] [Related]
5. Plasmacytoid/diffuse urothelial carcinoma: a single-institution immunohistochemical and molecular study of 69 patients.
Perrino CM; Eble J; Kao CS; Whaley RD; Cheng L; Idrees M; Hashemi-Sadraei N; Monn MF; Kaimakliotis HZ; Bandali E; Grignon D
Hum Pathol; 2019 Aug; 90():27-36. PubMed ID: 31054897
[TBL] [Abstract] [Full Text] [Related]
6. The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent fgfr3 mutation in Han Chinese patients.
Yuan X; Liu C; Wang K; Liu L; Liu T; Ge N; Kong F; Yang L; Björkholm M; Fan Y; Zhao S; Xu D
Oncotarget; 2016 May; 7(18):25826-35. PubMed ID: 27029078
[TBL] [Abstract] [Full Text] [Related]
7. Genomic Biomarkers for the Prediction of Stage and prognosis of Upper Tract Urothelial Carcinoma.
Bagrodia A; Cha EK; Sfakianos JP; Zabor EC; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA; Iyer G; Scott SN; Shah R; Ostrovnaya I; Lee B; Desai NB; Ren Q; Rosenberg JE; Dalbagni G; Bajorin DF; Reuter VE; Berger MF;
J Urol; 2016 Jun; 195(6):1684-1689. PubMed ID: 26778714
[TBL] [Abstract] [Full Text] [Related]
8. fgfr3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
van Oers JM; Zwarthoff EC; Rehman I; Azzouzi AR; Cussenot O; Meuth M; Hamdy FC; Catto JW
Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
[TBL] [Abstract] [Full Text] [Related]
